Thera technologies
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2015 Peel St 11TH Fl, Montreal, Quebec, ...Phone Number
(514) 336-7800Website
www.theratech.comRevenue
$50 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Thera technologies
Theratechnologies is a specialty biopharmaceutical company dedicated to developing and commercializing innovative therapies that aim to improve standards of care. The company focuses on prescription products for people living with HIV and advances research in specialized therapies targeting unmet medical needs in HIV, oncology, and rare or niche patient populations, emphasizing innovation and patient-centered solutions.Explore more
Thera technologies Org Chart
CM
Senior Director, Field Medical Affairs
EF
Senior Director, Pharmaceutical Development
RB
Global Senior Director, Medical Affairs
LD
Global Medical Director, Oncology
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Thera technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Thera technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Thera technologies recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Thera technologies is spiking on competitors!
Product Launch: Get notified when Thera technologies launches new products
Congratulate Masked Content for being promoted to Masked Content at Thera technologies
Check if Thera technologies has recently received funding, and reach out quickly before it becomes old news!
Click to see if Thera technologies had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Thera technologies has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Thera technologies
Compare insights from companies similar to Thera technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Thera technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Thera technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Thera technologies.
Thera technologies financials insights
Gather financial insights about Thera technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Debt
$40M
2024
Debt
$55M
Thera technologies Tech Stack
A closer look at the technologies used by Thera technologies
See more technologies
Most Recent Scoops
Product Launch
Product Development, Product Launch, Pharmaceuticals
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Earnings
Earnings, Finance
Funding
Funding
Thera technologies News & Media
Theratechnologies Announces Completion of Acquisition by Future Pak
MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the Business Corporations Act (Québec) involving CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), pursuant to which the Purchaser has acquired all the issued and outstTheratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak
MONTREAL, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that its shareholders have approved the previously announced plan of arrangement (the “Arrangement”) under Chapter XVI – Division II of the Business Corporations Act (Québec) involving CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”).Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
EGRIFTA WR™ offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV®Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
MONTREAL, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that two leading independent proxy advisory firms, Institutional Shareholders Services Inc. (“ISS”) and Glass Lewis & Co. LLC (“Glass Lewis”), have each recommended that the shareholders of the Company (the “Shareholders”) vote “FOR” the special resolution (the “Arrangement Resolution”) to approve
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Thera technologies
Sign Up For FreeTo access detailed company insights
Theratechnologies is a specialty biopharmaceutical company dedicated to developing and commercializing innovative therapies that aim to improve standards of care. The company focuses on prescription products for people living with HIV and advances research in specialized therapies targeting unmet medical needs in HIV, oncology, and rare or niche pa... Read More
